“kite-pharma” Archives

in
Entry Author Date Location
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial 12/06/16 Seattle
In Year of CAR-T Trouble, Can Bluebird, Penn Make Headway in Myeloma? 11/30/16 Boston
Two More Deaths In Trial Halt Juno’s Top CAR-T Treatment Again 11/23/16 Seattle
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? 09/29/16 San Francisco
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Alpine Immune Sciences, Former Dendreon CEO’s Latest Startup, Gets $48M 06/13/16 Seattle
Bankrupt Biotech KineMed Owes More Than $1M To Gates, Others 05/13/16 San Francisco
PureTech Gets into Cell Therapy With Vor Bio, But Keeps Details Close 05/09/16 Boston
West Coast Bio Roundup: UCLA Cashes In, BioMarin Tries Again & More 03/04/16 San Francisco
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
West Coast Biotech Roundup: Arena, Frazier, Kura, and Theranos 10/30/15 San Diego
Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy 09/18/15 National
With New Tools, Adaptive Bio Ready To Bolt Together A Drug Business 08/20/15 Seattle
West Coast Biotech Roundup: Bock, Celladon, Arivale, Conkwest & More 06/26/15 San Diego
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
IPO “On the Horizon” for Unum After $65M Series B, CEO Says 06/11/15 Boston
Seattle Genetics Pays $25M to Buy Into Unum’s Souped-Up T-Cell Therapy 06/08/15 Boston
Page 1 of 2 next page »